Women Health Therapeutics Market - Global Industry Analysis

Women Health Therapeutics Market- By Type (Infection, Pregnancy, and Oncology) and By Region- - Global Industry Perspective, Comprehensive Analysis, and Forecast, 2020 – 2026

Published Date: 26-Apr-2021 Category: Healthcare Report Format : PDF Pages: 125 Report Code: ZMR-6157 Status : Published

The global Women Health Therapeutics market accrued earnings worth approximately 110(USD Billion) in 2019 and is predicted to gain revenue of about 121 (USD Billion) by 2026, is set to record a CAGR of nearly 8.6% over the period from 2020 to 2026.

Description

The global Women Health Therapeutics market accrued earnings worth approximately 110(USD Billion) in 2019 and is predicted to gain revenue of about 121 (USD Billion) by 2026, is set to record a CAGR of nearly 8.6% over the period from 2020 to 2026. The report offers assessment and analysis of the Women Health Therapeutics market on a global and regional level. The study offers a comprehensive assessment of the market competition, constraints, revenue estimates, opportunities, evolving trends, and industry-validated data. The report provides historical data from 2017 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Billion).

Synopsis

Women health therapeutics has been gaining significance since last three decades. In 1991, NHLBI (National Heart, Lung, and Blood Institute) of the U.S. NIH (National Institutes of Health) sponsored the Women’s Health Initiative (WHI). As per this initiative, it focusses on various strategies including prevention of heart disorders, colorectal cancer, osteoporosis, and breast cancer in postmenopausal women over the long term. The key WHI study were divided into three parts, namely, clinical study, observational research, and community prevention study. The data collection for the WHI study was completed in 2005 by NIH. Furthermore, WHI contributes majorly towards women’s health & therapeutics through ancillary studies. All these aforementioned factors are anticipated to spearhead the growth of women health therapeutics industry.

Global Women-Health-Therapeutics-Market

Market Growth Drivers

Favorable initiatives carried out by NIH that include WHISH (Women’s Health Initiative Strong and Healthy Study), WHISPER (Women’s Health Initiative Sleep Hypoxia Effects on Resilience), and OPACH (Objective Physical Activity and Cardiovascular Health Study) will shape the market growth dimensions over the forecast period. Apart from this, constant surge in occurrence of chronic & lifestyle related diseases in women will embellish women health therapeutics market trends. Furthermore, rise in the funding of healthcare research events along with growing research in the field of oncology & breast cancer will form a strong foundation for women health therapeutics market. With rise in complications pertaining to pregnancy and launching of novel therapeutic drugs for treating the pregnancy related problems, women health therapeutics industry is slated to witness extensive surge within the next couple of years.

Moreover, increment in awareness associated with cancer, infections, menopause, and osteoporosis will proliferate the market size. New drug treatments introduced by giant players of pharma industry will chart a profitable roadmap for women health therapeutics market in the upcoming years. Rise in the infertility rates in women coupled with surge in the gynecological disorders will proliferate the industry size during the years ahead. Favorable government schemes supported by strong healthcare amenities in developed countries as well as emerging nations will kindle the emergence of the market over 2020-2026.

Regional Landscape

North America To Retain Regional Market Dominance Over 2020-2026

The business growth in North America over 2020-2026 can be attributed to large-scale approval of generic medicines by U.S. FDA and occurrence of chronic disorders in women population base. Apart from this, rise in geriatric female population prone to chronic disorders and introduction of new drug therapies to treat such severe ailments will augment market value and add to industry ascension during the assessment period. Moreover, U.S. and Canada are likely to be the key regional growth drivers within the span of next couple of years.

Report Scope

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Key players profiled in the study are Novartis International AG, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Merck & Co., Inc., Pfizer, Inc., Bayer AG, and Novo Nordisk A/S.

The global Women Health Therapeutics Market is segmented as follows:

 By Type  

  • Infection
  • Pregnancy
  • Oncology

By Region

 

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodulogy
      • 1.3.1. Market Research Type
      • 1.3.2. Market Research Methodulogy
  • Chapter 2. Executive Summary
    • 2.1. Women Health Therapeutics Market, 2016–2026(USD Billion)
    • 2.2. Women Health Therapeutics Market: Snapshot
  • Chapter 3. Global Women Health Therapeutics Market– Industry Analysis
    • 3.1. Women Health Therapeutics Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Bulge in awareness associated with cancer, infections, menopause, and osteoporosis among the population will pruliferate the market size.
      • 3.2.2. New drug treatments introduced by mammoth players of pharma industry will sketch a profitable growth graph for women health therapeutics market in the forthcoming years.
    • 3.3. Porter’s Five Forces Analysis
    • 3.4. Market Attractiveness Analysis
      • 3.4.1. Market attractiveness analysis By Type
  • Chapter 4. Global Women Health Therapeutics Market– Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Women Health Therapeutics Market: company market share, 2019
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Product launches
      • 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global Women Health Therapeutics Market– Type Analysis
    • 5.1. Global Women Health Therapeutics Market overview: By Type
      • 5.1.1. Global Women Health Therapeutics Market share, By Type , 2019 and 2026
    • 5.2. Infection
      • 5.2.1. Global Women Health Therapeutics Market by Infection, 2016–2026(USD Billion)
    • 5.3. Pregnancy
      • 5.3.1. Global Women Health Therapeutics Market by Pregnancy, 2016–2026(USD Billion)
    • 5.4. Onculogy
      • 5.4.1. Global Women Health Therapeutics Marketby Onculogy, 2016–2026(USD Billion)
  • Chapter 6. Company Profiles
    • 6.1. Novartis International AG
      • 6.1.1. Overview
      • 6.1.2. Financials
      • 6.1.3. Product Portfulio
      • 6.1.4. Business Strategy
      • 6.1.5. Recent Developments
    • 6.2. Eli Lilly and Company
      • 6.2.1. Overview
      • 6.2.2. Financials
      • 6.2.3. Product Portfulio
      • 6.2.4. Business Strategy
      • 6.2.5. Recent Developments
    • 6.3. F. Hoffmann-La Roche Ltd.
      • 6.3.1. Overview
      • 6.3.2. Financials
      • 6.3.3. Product Portfulio
      • 6.3.4. Business Strategy
      • 6.3.5. Recent Developments
    • 6.4. Abbott Laboratories
      • 6.4.1. Overview
      • 6.4.2. Financials
      • 6.4.3. Product Portfulio
      • 6.4.4. Business Strategy
      • 6.4.5. Recent Developments
    • 6.5. Merck & Co., Inc.
      • 6.5.1. Overview
      • 6.5.2. Financials
      • 6.5.3. Product Portfulio
      • 6.5.4. Business Strategy
      • 6.5.5. Recent Development
    • 6.6. Pfizer, Inc.
      • 6.6.1. Overview
      • 6.6.2. Financials
      • 6.6.3. Product Portfulio
      • 6.6.4. Business Strategy
      • 6.6.5. Recent Development
    • 6.7. Bayer AG
      • 6.7.1. Overview
      • 6.7.2. Financials
      • 6.7.3. Product Portfulio
      • 6.7.4. Business Strategy
      • 6.7.5. Recent Development
    • 6.8. Novo Nordisk A/S
      • 6.8.1. Overview
      • 6.8.2. Financials
      • 6.8.3. Product Portfulio
      • 6.8.4. Business Strategy
      • 6.8.5. Recent Development

Methodology


Frequently Asked Questions

Favorable initiatives carried out by NIH that include WHISH (Women’s Health Initiative Strong and Healthy Study), WHISPER (Women’s Health Initiative Sleep Hypoxia Effects on Resilience), and OPACH (Objective Physical Activity and Cardiovascular Health Study) will shape the market growth dimensions over the forecast period. Apart from this, constant surge in occurrence of chronic & lifestyle related diseases in women will embellish women health therapeutics market trends. Furthermore, rise in the funding of healthcare research events along with growing research in the field of oncology & breast cancer will form a strong foundation for women health therapeutics market. With rise in complications pertaining to pregnancy and launching of novel therapeutic drugs for treating the pregnancy related problems, women health therapeutics industry is slated to witness extensive surge within the next couple of years.

According to Zion market research report, the global Women Health Therapeutics market accrued earnings worth approximately 110(USD Billion) in 2019 and is predicted to gain revenue of about 121 (USD Billion) by 2026, is set to record a CAGR of nearly 8.6% over the period from 2020 to 2026.

North America will contribute lucratively towards the global market value over the estimated timeline. The growth of the regional market during the forecast timespan can be attributed to large-scale approval of generic medicines by U.S. FDA and occurrence of chronic disorders in women population base. Apart from this, rise in geriatric female population prone to chronic disorders and introduction of new drug therapies to treat such severe ailments will augment market value and add to industry ascension during the assessment period. Moreover, U.S. and Canada are likely to be the key regional growth drivers within the span of next couple of years.

The key market participants include Novartis International AG, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Merck & Co., Inc., Pfizer, Inc., Bayer AG, and Novo Nordisk A/S.

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Corporate Office

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Are On Social